Management of Status Epilepticus

Introduction

Convulsive status epilepticus (continuing or recurrent seizures over 5 minutes, or without recovery) is a medical emergency with a 16–39% mortality rate. There is a risk that seizures will cause cerebral damage if not controlled within 30 minutes of onset.

This guideline contains brief guidance on the management of convulsive status epilepticus stages 1 -3 (the first 30minutes) in adults who are ≥16 years old and not pregnant. Further information, including ongoing management once seizures are controlled, is available in the full guideline on AthenA / Guidelines - Prescribing. The guidance is based on the SIGN guideline for diagnosis and management of epilepsy in adults and up-to-date trial information. Treatment may differ in individual clinical circumstances. If your patient is pregnant, consult specialist guidelines for advice.

Drug Therapy

For the treatment pathway of convulsive status epilepticus (stages 1-3), as well as the choice of antiepileptic drug:

More detail regarding choice, dosage and administration of antiepileptic drugs can be found by following the relevant links below:

Once seizures are controlled, follow guidance for ongoing management here.

N.B. The full guideline can be found on AthenA / Guidelines - Prescribing.

 

Guideline reviewed: August 2022 (minor update October 2024)

Page updated: November 2024




;